Fierce Healthcare

DECEMBER 8, 2023

Healthcare technology giant Epic is leveraging its massive clinical research database, with data on 226 million patients, to develop a next-generation decision support tool for clinicians.

79

79

pharmaphorum

NOVEMBER 15, 2022

For the clinical trials industry, the pandemic forced new ways of working and fresh ways of thinking about clinical research and how to conduct it remotely. The alternative was unthinkable: halting all clinical research to the detriment of patients who so desperately need new medicines. It caused intense suffering and tragedy.

Vaccines 105

Vaccines 105

European Pharmaceutical Review

APRIL 12, 2024

There has been a “notable” rise in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology for gene therapies over the past five years, according to data and analytics firm GlobalData. These agreements have amassed a total deal value of $21 billion.

FDA 88

FDA 88

STAT

JANUARY 8, 2024

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract. health system.

Mayo Clinic 132

Mayo Clinic 132

STAT

AUGUST 17, 2023

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. There are many potential advantages to using wearables in clinical trials. The Pensacola, Fla.-based The industry has yet to see a drug approved with evidence from a wearable device.

96

96

European Pharmaceutical Review

NOVEMBER 28, 2022

FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice.

Hospitals 96

Hospitals 96

European Pharmaceutical Review

MARCH 12, 2024

Data integrity is the term used to describe the accuracy, consistency and reliability of data throughout its lifecycle. In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health.

Documentation 94

Documentation Data Entry Communication Compounding 94

Pharmaceutical Technology

JANUARY 16, 2023

One such emerging technology, artificial intelligence (AI), is expected to play an important role in the pharmaceutical sector in 2023. AI has been voted as the most disruptive emerging technology every year since 2020, according to the survey tracker.

Pharmaceutical Companies 121

Pharmaceutical Companies Pharmaceutical Companies Vaccines 121

Fierce Healthcare

NOVEMBER 30, 2023

AI and the machine learning technologies behind it are starting to find their way into healthcare, taking some of the drudgery out of producing clinical notes and billing claims, as well as helping researchers unlock some of their data.

Customer Service 96

Customer Service 96

pharmaphorum

DECEMBER 18, 2023

AI-driven text analytics can revolutionise the clinical trial process by improving data collection and analysis in the biopharma industry. Learn how this technology can enhance efficiency and patient outcomes.

68

68

ISPE

MAY 16, 2023

Yet despite many of the external challenges the core technology behind blockchains has remained secure, available, and immutable – just as they were designed to do. According to a report by Grand View Research, the global blockchain technology market in healthcare is expected to grow at a compound annual growth rate (CAGR) of 66.1%

Compounding 98

Compounding 98

pharmaphorum

OCTOBER 19, 2021

A new poll of clinical trial sponsors has found that around nine out of 10 of them are running decentralised trials with the help of digital technologies, a big increase on pre-COVID-19 levels. The objective is to improve information sharing and collaboration, better support clinical investigation sites, and eliminate data silos.

137

137

European Pharmaceutical Review

MAY 11, 2023

the organisation has seen “a rapid growth in the number of submissions that reference AI/ML” over the past few years” These are: Human-led governance, accountability and transparency Quality, reliability and representativeness of data Model development, performance, monitoring and validation.

FDA 90

FDA Communication 90

PharmExec

JULY 20, 2022

Thursday, July 21st 2022 at 11am EST, 8am PST, 5pm CEST Join this webinar to hear industry thought leaders discuss how data and experiences serve clinical and commercial needs, explore which platforms and technologies can enable a robust digital health ecosystem, and share recommendations for building a digital health strategy fit for your business. (..)

139

139

STAT

SEPTEMBER 5, 2023

Health care leaders and technology companies are investing heavily in large language models, a powerful class of deep learning models that are trained on vast troves of data. But while enthusiasm for generative AI is high and research is booming, it’s just starting to gain a toehold in clinical settings.

Hospitals 142

Hospitals 142

Omnicell

JANUARY 10, 2023

We’re in Las Vegas this week attending HIMSS21, meeting with chief innovation officers, chief technology officers, vice presidents of IT, and clinical leaders to showcase how the Autonomous Pharmacy supports this year’s conference theme: Be the Change. The 2019 HIMSS U.S. billion dollars. billion dollars.

Omnicell 98

Omnicell Patient Care 98

STAT

JANUARY 30, 2024

The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., Continue to STAT+ to read the full story…

144

144

pharmaphorum

AUGUST 3, 2022

We all know that real-world data (RWD) from electronic health records (EHR) could boost clinical trial efficiency and improve patient outcomes – so what’s holding us back? It’s been more than two decades since the ground-breaking potential of using electronic health records (EHR) to inform clinical research was first mooted.

Cerner 123

Cerner FDA 123

pharmaphorum

DECEMBER 23, 2021

The FDA has published draft guidance on how digital health technologies (DHTs) like smart and wearable devices can be used to capture data remotely from patients in clinical trials – an approach that has come to the fore since the start of the pandemic. The draft is open for comment until 22 March.

FDA 117

FDA Documentation 117

STAT

JUNE 7, 2023

Google will embed its generative AI technology into computer systems at Mayo Clinic and other health systems to make it easier to search vast repositories of patient data and automate administrative tasks, the organizations said Wednesday. Continue to STAT+ to read the full story…

Mayo Clinic 103

Mayo Clinic HIPAA Hospitals 103

STAT

NOVEMBER 2, 2022

Editas Medicine’s new leadership team on Wednesday reiterated a promise to deliver clinical updates on two CRISPR-based treatments before the end of the year — data the troubled biotech hopes will ease investor doubts about its gene-editing technology.

120

120

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use.

FDA 99

FDA 99

European Pharmaceutical Review

AUGUST 31, 2023

Based on new data from the Novartis Phase I/II clinical trial , which used the first therapy to target a new genetic area and use cryopreserved stem cells, trial participants reported a decrease in vaso-occlusive events. It is the second therapy to use CRISPR-Cas9 technology for sickle cell disease.

Hospitals 111

Hospitals FDA 111

Pharma Mirror

JUNE 15, 2023

In recent years, the field of clinical trials has witnessed a significant transformation due to advancements in technology. The integration of technology into clinical trials has revolutionized the way researchers conduct studies, collect data, and analyze results.

52

52

European Pharmaceutical Review

OCTOBER 26, 2023

Following the recent 2023 European Society for Medical Oncology (ESMO) meeting, Dr Mark Rutstein, Senior Vice President, Head of Oncology Clinical Development at Daiichi Sankyo , summarises key data for the ADC datopotamab deruxtecan (Dato-DXd) and its potential in oncology, particularly for breast and lung cancer.

Chemotherapy 100

Chemotherapy 100

pharmaphorum

JANUARY 11, 2023

Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information. Data generation and chess.

Compounding 121

Compounding 121

European Pharmaceutical Review

MAY 26, 2023

The UK Chancellor has announced a £650 million life sciences growth package (Life Sci for Growth) to help deliver the Science and Technology framework through reforming regulation, boosting investment and driving up talent and skills.

Packaging 104

Packaging Vaccines 104

STAT

FEBRUARY 16, 2024

insurance claims data compiled by health technology company Komodo Health. Just a week after dropping the development of a treatment for blood cancers, Gilead Sciences has paused enrollment in clinical trials of the same drug in solid tumors, adding to concerns about its side effects , Pharmaphorum explains. The

Insurance 99

Insurance 99

pharmaphorum

NOVEMBER 25, 2022

million) in funding to a new project that aims to boost the ability of hospitals within the EU to collect real-world data (RWD) to gauge the effectiveness of novel cancer therapies. It is being led by Helsinki University Hospital (HUS), with Swiss data specialist BC Platforms selected as one of the technology partners for the project.

Hospitals 90

Hospitals 90

European Pharmaceutical Review

DECEMBER 12, 2023

Additionally, Morel shares highlights and key clinical data from Innate Pharma’s pipeline and as well as his predictions on where the sector is headed, meanwhile considering the impact of accelerating technological innovations. Innate Pharma is an international clinical-stage biotechnology oncology company based in France.

Immunization 113

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 113

European Pharmaceutical Review

MAY 22, 2023

While the counterfeit market is estimated to be a market of over $200 billion and despite its benefits, blockchain technology has not been fully implemented in the pharmaceutical supply chain, according to the paper. This can reduce the willingness for counterfeit and less accurate data, according to the review.

95

95

The FDA Law Blog

OCTOBER 18, 2023

Lenz, Principal Medical Device Regulation Expert — Although it seems not widely known outside of the medical device industry, FDA can require sponsors to include clinical data as part of a 510(k) submission.

FDA 64

FDA Medical Records 64

Roots Analysis

AUGUST 17, 2023

In recent years, blockchain has garnered significant interest of researchers, as well as industry players, as it has proven to be a versatile tool for decentralized monetary transactions and data exchange in various industries, such as banking, cyber security, supply chain management, government and healthcare.

52

52

Fierce Pharma

OCTOBER 26, 2023

By Thomas Pietsch, Global Head of Scientific Data Technology and AI, Parexel International | AI holds unlimited potential to change today’s clinical development paradigm. Explore three broad areas where it could be especially useful today.

58

58

pharmaphorum

JUNE 1, 2022

Medical imaging specialist Median Technologies has launched a new business unit that will provide decision-making tools – underpinned by artificial intelligence – for sponsors of clinical trials in oncology. sensitivity and 93.3% specificity in detecting cancer in lung nodules from a cohort of 1,760 patients.

FDA 98

FDA 98

Hospital Pharmacy Europe

FEBRUARY 16, 2024

A new international project aiming to use artificial intelligence (AI) and genomics data to personalise therapies for patients with cardiovascular disease (CVD) has been announced. Personalised medicine is, therefore, the way forward for preventing heart disease, speeding up diagnosis, and monitoring and treating people with CVD. ‘To

Hospitals 52

Hospitals 52

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense software is developed specifically for analysis of data from wearable sensors”, explains Tabakin. In this way, you’re eliminating that variability.”.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Packaging 110